Liminatus Pharma, Inc. (LIMN)
3.76
+0.07
(+1.90%)
USD |
NASDAQ |
Oct 09, 16:00
3.78
+0.02
(+0.53%)
After-Hours: 20:00
Liminatus Pharma Market Cap : 0.0842M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.0842M |
| October 08, 2026 | 0.0827M |
| October 07, 2026 | 0.0869M |
| October 06, 2026 | 0.0829M |
| October 05, 2026 | 0.0894M |
| October 02, 2026 | 0.0874M |
| October 01, 2026 | 0.084M |
| September 30, 2026 | 0.0836M |
| September 29, 2026 | 0.0876M |
| September 28, 2026 | 0.0956M |
| September 25, 2026 | 0.094M |
| September 24, 2026 | 0.0936M |
| September 23, 2026 | 0.0903M |
| September 22, 2026 | 0.0912M |
| September 21, 2026 | 0.0815M |
| September 18, 2026 | 0.078M |
| September 17, 2026 | 0.0759M |
| September 16, 2026 | 0.0746M |
| September 15, 2026 | 0.0786M |
| September 14, 2026 | 0.0788M |
| September 11, 2026 | 0.0777M |
| September 10, 2026 | 0.0813M |
| September 09, 2026 | 0.078M |
| September 08, 2026 | 0.0811M |
| September 04, 2026 | 0.0831M |
| Date | Value |
|---|---|
| September 03, 2026 | 0.0829M |
| September 02, 2026 | 0.086M |
| September 01, 2026 | 0.0816M |
| August 31, 2026 | 0.0865M |
| August 28, 2026 | 0.0948M |
| August 27, 2026 | 0.0986M |
| August 26, 2026 | 0.0988M |
| August 25, 2026 | 0.1033M |
| August 24, 2026 | 0.1046M |
| August 21, 2026 | 0.1156M |
| August 20, 2026 | 0.1261M |
| August 19, 2026 | 0.1251M |
| August 18, 2026 | 0.1456M |
| August 17, 2026 | 395.72M |
| August 14, 2026 | 391.80M |
| August 13, 2026 | 419.51M |
| August 12, 2026 | 303.65M |
| August 11, 2026 | 312.04M |
| August 10, 2026 | 327.43M |
| August 07, 2026 | 288.25M |
| August 06, 2026 | 276.78M |
| August 05, 2026 | 293.85M |
| August 04, 2026 | 330.79M |
| August 03, 2026 | 318.20M |
| July 31, 2026 | 288.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
| Vericel Corp. | 2.052B |
Market Cap Related Metrics
| Price to Book Value | 0.2802 |
| Price | 3.76 |
| Earnings Yield | -28.57K% |